
    
      A pivotal, randomized, open label, assessor-blinded, 90-day study designed to compare the
      safety, performance and efficacy of thrombus removal in subjects aged â‰¥ 18 years presenting
      with acute ischemic stroke with the NeVa versus the Solitaire stent retrievers.

      A total of 414 eligible subjects will be randomized in a 1:1 ratio to one of two treatment
      groups:

        -  Active Treatment Group

        -  Control Device
    
  